treatment of impalpable testis

Phase 2

• Conditions: impalpable testis.; Undescended testicle, unilateral, Undescended testicle, bilateral, Undescended testicle, unspecified; Q53.1, Q53

• Registration Number: IRCT201103015945N1
• Lead Sponsor: Vice chancellor of research for Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 50

Inclusion Criteria

inclusion criteria: aging range between 1 to 12 year's old ; patients with bilateral undescended testis without response to medical treatment with HCG

Exclusion criteria: nonacceptance of patient's parents ; palpation of testis after anesthesia and before operation ; patient's death before ending of following time

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Testis existence in scrotum. Timepoint: 6 month. Method of measurement: palpation.

Secondary Outcome Measures

Name	Time	Method
Scrotal hematoma. Timepoint: during 6 month after intervention. Method of measurement: observation and examination.;Surgical site infection. Timepoint: During 6 month after intervention. Method of measurement: Observation & examination.;Damage formation to gonadal vessels. Timepoint: During 6 month after intervention. Method of measurement: Observation & examination.;Injury to the vas deferens. Timepoint: During 6 month after intervention. Method of measurement: Observation & examination.;Mortality rate. Timepoint: During 6 month after intervention. Method of measurement: Observation & examination.